Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to...

TL;DR


Summary:
- This article provides a comprehensive review of the role of the NLRP3 inflammasome in the pathogenesis of autoimmune diseases, specifically focusing on its activation mechanisms and regulatory pathways.
- It explores the therapeutic potential of targeting NLRP3-mediated signaling cascades as a precision medicine approach for treating complex inflammatory disorders.

Like summarized versions? Support us on Patreon!